DIVISLAB's weekly performance was modest, with a return of 0.75%, but accompanied by high volatility of 47.75%. This week, the stock outperformed DRREDDY and SUNPHARMA, but underperformed CIPLA. The stock's Sharpe Ratio of 0.06 indicates a relatively low risk-adjusted return, and the Max Drawdown of -2.99% suggests a moderate level of risk. Overall, DIVISLAB's performance was decent, but its high volatility makes it a relatively risky investment.

[Volatility: 47.75%]